十一月 2025
- Home
- AllCells
十一月 2025的AllCells市场份额分析
Purchase high quality human primary cells from peripheral blood and bone marrow for medical, scientific, and academic research. Cryopreserved and fresh cells delivered on time and on budget.
AllCells(包含公司地区分支机构)
查看更多网站流量和参与度信息- allcells.com
AllCells收入截至 十一月 2025为 15M - 25M
AllCells主要域名产生的收入
3 年中AllCells主要域名的收入
AllCells主要域名的收入
AllCells热门域名的总访问量
了解AllCells市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
AllCells热门域名的平均访问时长
分析AllCells参与度指标。
过去 3 个月的平均访问时长
子公司明细
AllCells热门域名的平均页面浏览量
了解AllCells如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
AllCells 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻AllCells, LLC launched Pre-Characterized Donor Selection Program on Jul 3rd '23.AllCells has recently introduced the Pre-Characterized Donor Selection Program designed to expedite screening, selecting, and collecting from eligible donors (Figure 1) for downstream clinical manufacturing.
八月 3, 2023阅读更多
新闻AllCells, LLC expands facilities to Houston, Texas, United States.AllCells®, a Discovery Life Sciences™ company and leading provider of critical starting material and services for cell and gene therapy (CGT), has announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama.
二月 22, 2023阅读更多
新闻Discoverylifesciences acquired AllCells, LLC on Jul 1st '22.Ares served as the administrative agent, lead arranger, and bookrunner for a senior secured credit facility to support Discovery Life Sciences’ acquisition of AllCells.
十月 27, 2022阅读更多
查看 AllCells 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。